Pre-market
Loading markets…

Advertisement

Stocks

Why Extendicare Inc stock is tanking today

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:EXE.TO

Follow EXE

Photos provided by Pexels

Extendicare Inc's stock has taken a notable hit, dropping 1.89% in the last trading session, closing at CA$33.18.

In a challenging market session, Extendicare Inc (EXE.TO) saw its stock price decline by 1.89%, reflecting investor concerns about the company's recent performance and market conditions. With a market cap of approximately CA$3.13 billion, this drop raises questions about the future trajectory of the company amidst its ongoing expansion efforts.

Investor takeaway: While Extendicare has been actively pursuing growth through acquisitions and increasing its dividend, the recent stock decline suggests that investors are cautious about its short-term outlook.

Advertisement

Extendicare Inc

EXE.TO

Full stock page →

EXE.TO

Extendicare Inc

Source:WealthAwesomeWealthAwesome
$4.14 (14.91%)
120 day period
$27.76$33.27$38.79Apr 2Jun 29Sep 23

Market cap

$3.03B

P/E

24.4x

Div. yield

1.65%

Div. / share

$0.51

52W high

$39.04

52W low

$14.12

1W change

+1.24%

Beta

1.11

Analyst Price Targets

Based on analyst covering EXE · as of Sep 17, 2026

📈

Wall Street analysts forecast EXE stock price to rise 28.0% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$39.83

+28.0% Upside

Current Price

C$31.12

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on EXE's historical volatility

HistoricalForecast68%95%
C$19.22C$23.37C$27.51C$31.66C$35.81C$39.95TodayMay 15Jul 21Sep 23Nov 5Dec 19Jan 31

30-Day Vol

27.1%

Annualized

90-Day Vol

30.9%

Annualized

Trend (90d)

-42.8%

Annualized drift

90d Mean

C$27.38

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$30.32C$27.61C$33.28
60 trading daysC$28.81C$25.25C$32.88
90 trading daysC$27.38C$23.29C$32.19

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

1.89% Drop in Stock Price

Extendicare's stock closed at CA$33.18, down from the previous day, reflecting investor apprehension.

Bull case

Extendicare's recent financial results showed a significant increase in adjusted EBITDA, which indicates strong operational performance and potential for future growth. This suggests that the company is on a solid path, despite current market challenges.

Bear case

The stock's decline today could signal underlying concerns about the company's ability to sustain growth amidst rising operational costs and market volatility. Investors may be worried about how these factors will affect Extendicare's long-term success.

Advertisement

Market Reaction to Extendicare's Performance

The recent drop in Extendicare's stock price comes despite a reported 52.2% increase in adjusted EBITDA for Q1 2026. Investors may be weighing the implications of rising operational costs and the competitive landscape in the healthcare sector. The company's recent acquisition of nine long-term care homes is a strategic move, but concerns about integration and profitability may be affecting investor confidence.

Investor Sentiment and Future Outlook

With a P/E ratio of 24.87 and a modest dividend yield of 1.53%, Extendicare's valuation metrics suggest a premium price that could be difficult to sustain if market conditions do not improve. The stock's decline today highlights the need for investors to closely monitor the company's performance and strategic direction as it navigates the complexities of the healthcare market. For more insights on Extendicare's financials, check out our detailed analysis on EXE.TO.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: June 17, 2026
Last Updated: June 17, 2026

Core portfolio

Awesome Portfolio™

15.1% a year since 2017, against 9.9% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+15.1%

Awesome Portfolio™

+9.9%

S&P/TSX

+5.2 pp better a year

Total return

+260%

Awesome Portfolio™

+137%

S&P/TSX

+123 pp better than the TSX

2017-07-31 to 2026-09-17, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-17
-11.7%42.8%97.2%151.6%206.0%260.4%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement